These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2623545)

  • 41. [Erythrocyte filterability in Raynaud's disease].
    Sciannameo F; Francucci M; Cao PG; Marianeschi P; Valentini M; Tockner M; Sassano L; Grasselli A
    Ric Clin Lab; 1983; 13 Suppl 3():475-80. PubMed ID: 6673030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Raynaud's phenomenon and systemic diseases.
    Kallenberg CG
    Vasa Suppl; 1987; 18():15-20. PubMed ID: 3299813
    [No Abstract]   [Full Text] [Related]  

  • 43. Blood flow through the brachial artery at different temperatures in patients with Raynaud's phenomenon.
    Savin E; Kedra W; Oliva I; Prerovský I; Martineaud JP
    Cor Vasa; 1989; 31(4):299-305. PubMed ID: 2805704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
    Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
    J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Finger plethysmography for studying the blood rheological and hemodynamic components of an acrosyndrome].
    de Faucal P; Planchon B; Boudard D; Peltier P; Barrier J; Grolleau JY
    J Mal Vasc; 1986; 11(4):356-61. PubMed ID: 3805897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Digital blood flow measurement by venous occlusion plethysmography in Raynaud's phenomenon. Value of the rewarming test].
    Cristol R; Debray J
    J Mal Vasc; 1986; 11(1):85-9. PubMed ID: 3944527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
    Henness S; Wigley FM
    Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evaluation of Panergon therapy in Raynaud syndrome within the scope of progressive scleroderma].
    Bosmanský K; Tauchmannová H; Lukác J; Zitnan D
    Z Rheumatol; 1985; 44(5):242-5. PubMed ID: 4082792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon.
    Marasini B; Casari S; Bestetti A; Maioli C; Cugno M; Zeni S; Turri O; Guagnellini E; Biondi ML
    J Rheumatol; 2000 Nov; 27(11):2621-3. PubMed ID: 11093443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxidant/antioxidant status in patients with Raynaud's disease.
    Biondi R; Coaccioli S; Lattanzi S; Puxeddu A; Papini M
    Clin Ter; 2008; 159(2):77-81. PubMed ID: 18463765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between nailfold capillary microscopy and salivary capillary basement membrane width in Raynaud's disease and progressive systemic sclerosis.
    DeBure C; Fiessinger JN; Priollet P; Camilleri JP; Vayssairat M; Kazandjian S; Housset E
    J Rheumatol; 1985 Apr; 12(2):279-82. PubMed ID: 4032402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
    Wigley FM
    Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of computer-assisted Doppler sonography and rheography in acral vascular diagnosis in progressive systemic sclerosis].
    Jäger H; Gräfenstein K; Petzold M; Löffler S
    Z Gesamte Inn Med; 1990 May; 45(10):287-9. PubMed ID: 2203209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet serotonin in systemic sclerosis.
    Klimiuk PS; Grennan A; Weinkove C; Jayson MI
    Ann Rheum Dis; 1989 Jul; 48(7):586-9. PubMed ID: 2774700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemorheological factors in Raynaud's phenomenon.
    Dintenfass L
    Angiology; 1977 Jul; 28(7):472-81. PubMed ID: 900567
    [No Abstract]   [Full Text] [Related]  

  • 56. Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon.
    Kundu D; Abraham D; Black CM; Denton CP; Bruckdorfer KR
    Vascul Pharmacol; 2014 Dec; 63(3):178-81. PubMed ID: 25446164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered behaviour of erythrocytes in scleroderma.
    Kovacs IB; Sowemimo-Coker SO; Kirby JD; Turner P
    Clin Sci (Lond); 1983 Nov; 65(5):515-9. PubMed ID: 6617097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies of endogenous catecholamines in patients with Raynaud's phenomenon secondary to progressive systemic sclerosis (scleroderma).
    Sapira JD; Rodnan GP; Scheib ET; Klaniecki T; Rizk M
    Am J Med; 1972 Mar; 52(3):330-7. PubMed ID: 4551793
    [No Abstract]   [Full Text] [Related]  

  • 59. Serum type III procollagen peptide concentrations in systemic sclerosis and Raynaud's phenomenon: relationship to disease activity and duration.
    Black CM; McWhirter A; Harrison NK; Kirk JM; Laurent GJ
    Br J Rheumatol; 1989 Apr; 28(2):98-103. PubMed ID: 2706431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium influx into red blood cells: the effect of sera from patients with systemic sclerosis.
    Rademaker M; Thomas RH; Kirby JD; Kovacs IB
    Clin Exp Rheumatol; 1991; 9(3):247-51. PubMed ID: 1879084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.